Filing Details

Accession Number:
0001237899-15-000049
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-17 16:01:52
Reporting Period:
2015-08-13
Filing Date:
2015-08-17
Accepted Time:
2015-08-17 16:01:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377247 Peter Powchik 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Clinical Development & Reg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-13 10,000 $270.43 25,821 No 4 M Direct
Common Stock Disposition 2015-08-13 4,667 $579.35 21,154 No 4 F Direct
Common Stock Disposition 2015-08-13 2,749 $579.35 18,405 No 4 F Direct
Common Stock Acquisiton 2015-08-13 14,625 $179.13 33,030 No 4 M Direct
Common Stock Disposition 2015-08-13 4,521 $579.35 28,509 No 4 F Direct
Common Stock Disposition 2015-08-13 5,210 $579.35 23,299 No 4 F Direct
Common Stock Acquisiton 2015-08-13 23,000 $52.03 46,299 No 4 M Direct
Common Stock Disposition 2015-08-13 2,065 $579.35 44,234 No 4 F Direct
Common Stock Disposition 2015-08-13 10,795 $579.35 33,439 No 4 F Direct
Common Stock Acquisiton 2015-08-13 8,000 $52.03 41,439 No 4 M Direct
Common Stock Disposition 2015-08-13 718 $579.35 40,721 No 4 F Direct
Common Stock Disposition 2015-08-13 3,755 $579.35 36,966 No 4 F Direct
Common Stock Acquisiton 2015-08-13 4,736 $30.63 41,702 No 4 M Direct
Common Stock Disposition 2015-08-13 250 $579.35 41,452 No 4 F Direct
Common Stock Disposition 2015-08-13 2,146 $579.35 39,306 No 4 F Direct
Common Stock Disposition 2015-08-14 1,405 $569.63 37,901 No 4 S Direct
Common Stock Disposition 2015-08-14 3,603 $570.63 34,298 No 4 S Direct
Common Stock Disposition 2015-08-14 5,598 $571.54 28,700 No 4 S Direct
Common Stock Disposition 2015-08-14 2,800 $572.60 25,900 No 4 S Direct
Common Stock Disposition 2015-08-14 2,717 $573.64 23,183 No 4 S Direct
Common Stock Disposition 2015-08-14 900 $574.75 22,283 No 4 S Direct
Common Stock Disposition 2015-08-14 700 $575.47 21,583 No 4 S Direct
Common Stock Disposition 2015-08-14 2,004 $576.65 19,579 No 4 S Direct
Common Stock Disposition 2015-08-14 2,258 $577.75 17,321 No 4 S Direct
Common Stock Disposition 2015-08-14 1,500 $578.63 15,821 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-13 4,736 $0.00 4,736 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-13 23,000 $0.00 23,000 $52.03
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-13 8,000 $0.00 8,000 $52.03
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-13 14,625 $0.00 14,625 $179.13
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-13 10,000 $0.00 10,000 $270.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-14 No 4 M Direct
14,079 2021-12-16 No 4 M Direct
6,079 2021-12-16 No 4 M Direct
29,250 2022-12-14 No 4 M Direct
30,000 2023-12-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,890 Indirect by GRAT
Common Stock 1,652 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 1,405 shares of Company stock on August 14, 2015 at prices ranging from $569.11 to $570.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  2. Represents volume-weighted average price of sales of 3,603 shares of Company stock on August 14, 2015 at prices ranging from $570.15 to $571.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  3. Represents volume-weighted average price of sales of 5,598 shares of Company stock on August 14, 2015 at prices ranging from $571.14 to $572.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  4. Represents volume-weighted average price of sales of 2,800 shares of Company stock on August 14, 2015 at prices ranging from $572.23 to $573.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  5. Represents volume-weighted average price of sales of 2,717 shares of Company stock on August 14, 2015 at prices ranging from $573.15 to $574.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  6. Represents volume-weighted average price of sales of 900 shares of Company stock on August 14, 2015 at prices ranging from $574.20 to $575.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  7. Represents volume-weighted average price of sales of 700 shares of Company stock on August 14, 2015 at prices ranging from $575.30 to $576.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  8. Represents volume-weighted average price of sales of 2,004 shares of Company stock on August 14, 2015 at prices ranging from $576.16 to $577.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  9. Represents volume-weighted average price of sales of 2,258 shares of Company stock on August 14, 2015 at prices ranging from $577.24 to $578.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  10. Represents volume-weighted average price of sales of 1,500 shares of Company stock on August 14, 2015 at prices ranging from $578.14 to $579.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
  11. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  12. The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.
  13. The stock option award vests in four equal annual installments, commencing one year after the date of grant.